Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 619 entries
Sorted by: Best Match Show Resources per page
Highly efficient large-area colourless luminescent solar concentrators using heavy-metal-free colloidal quantum dots.

Nature nanotechnology

Meinardi F, McDaniel H, Carulli F, Colombo A, Velizhanin KA, Makarov NS, Simonutti R, Klimov VI, Brovelli S.
PMID: 26301902
Nat Nanotechnol. 2015 Oct;10(10):878-85. doi: 10.1038/nnano.2015.178. Epub 2015 Aug 24.

Luminescent solar concentrators serving as semitransparent photovoltaic windows could become an important element in net zero energy consumption buildings of the future. Colloidal quantum dots are promising materials for luminescent solar concentrators as they can be engineered to provide...

Cite
Meinardi F, McDaniel H, Carulli F, et al. Highly efficient large-area colourless luminescent solar concentrators using heavy-metal-free colloidal quantum dots. Nat Nanotechnol. 2015;10(10):878-85doi: 10.1038/nnano.2015.178.
Meinardi, F., McDaniel, H., Carulli, F., Colombo, A., Velizhanin, K. A., Makarov, N. S., Simonutti, R., Klimov, V. I., & Brovelli, S. (2015). Highly efficient large-area colourless luminescent solar concentrators using heavy-metal-free colloidal quantum dots. Nature nanotechnology, 10(10), 878-85. https://doi.org/10.1038/nnano.2015.178
Meinardi, Francesco, et al. "Highly efficient large-area colourless luminescent solar concentrators using heavy-metal-free colloidal quantum dots." Nature nanotechnology vol. 10,10 (2015): 878-85. doi: https://doi.org/10.1038/nnano.2015.178
Meinardi F, McDaniel H, Carulli F, Colombo A, Velizhanin KA, Makarov NS, Simonutti R, Klimov VI, Brovelli S. Highly efficient large-area colourless luminescent solar concentrators using heavy-metal-free colloidal quantum dots. Nat Nanotechnol. 2015 Oct;10(10):878-85. doi: 10.1038/nnano.2015.178. Epub 2015 Aug 24. PMID: 26301902.
Copy Download .nbib Format: NLM
Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation.

Patient related outcome measures

Maggiolo F, Colombo GL, Di Matteo S, Bruno GM, Astuti N, Di Filippo E, Masini G, Bernardini C.
PMID: 25733942
Patient Relat Outcome Meas. 2015 Feb 17;6:53-60. doi: 10.2147/PROM.S63586. eCollection 2015.

OBJECTIVES: Costs may play a role in deciding how and when to start highly active antiretroviral therapy (HAART) in a naïve patient. The aim of the present study was to assess the cost- effectiveness of treatment with HAART in...

Cite
Maggiolo F, Colombo GL, Di Matteo S, et al. Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation. Patient Relat Outcome Meas. 2015;6:53-60doi: 10.2147/PROM.S63586.
Maggiolo, F., Colombo, G. L., Di Matteo, S., Bruno, G. M., Astuti, N., Di Filippo, E., Masini, G., & Bernardini, C. (2015). Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation. Patient related outcome measures, 653-60. https://doi.org/10.2147/PROM.S63586
Maggiolo, Franco, et al. "Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation." Patient related outcome measures vol. 6 (2015): 53-60. doi: https://doi.org/10.2147/PROM.S63586
Maggiolo F, Colombo GL, Di Matteo S, Bruno GM, Astuti N, Di Filippo E, Masini G, Bernardini C. Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation. Patient Relat Outcome Meas. 2015 Feb 17;6:53-60. doi: 10.2147/PROM.S63586. eCollection 2015. PMID: 25733942; PMCID: PMC4337626.
Copy Download .nbib Format: NLM
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality.

Transplantation direct

Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, Trucchi C, Alicino C, Sartor A, Wauters J, Lagrou K, Tascini C, Menichetti F, Mesini A, De Rosa FG, Lagunes L, Rello J, Colombo AL, Vena A, Munoz P, Tumbarello M, Sganga G, Martin-Loeches I, Viscoli C.
PMID: 28573191
Transplant Direct. 2017 Apr 18;3(5):e156. doi: 10.1097/TXD.0000000000000673. eCollection 2017 May.

BACKGROUND: Invasive fungal infections remain a leading cause of morbidity and mortality among liver transplant recipients (LTRs). In this patient population, invasive Candida infections (ICIs) account for the large majority of cases. To date, only small studies and case-series...

Cite
Bassetti M, Peghin M, Carnelutti A, et al. Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality. Transplant Direct. 2017;3(5):e156doi: 10.1097/TXD.0000000000000673.
Bassetti, M., Peghin, M., Carnelutti, A., Righi, E., Merelli, M., Ansaldi, F., Trucchi, C., Alicino, C., Sartor, A., Wauters, J., Lagrou, K., Tascini, C., Menichetti, F., Mesini, A., De Rosa, F. G., Lagunes, L., Rello, J., Colombo, A. L., Vena, A., Munoz, P., Tumbarello, M., Sganga, G., Martin-Loeches, I., & Viscoli, C. (2017). Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality. Transplantation direct, 3(5), e156. https://doi.org/10.1097/TXD.0000000000000673
Bassetti, Matteo, et al. "Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality." Transplantation direct vol. 3,5 (2017): e156. doi: https://doi.org/10.1097/TXD.0000000000000673
Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, Trucchi C, Alicino C, Sartor A, Wauters J, Lagrou K, Tascini C, Menichetti F, Mesini A, De Rosa FG, Lagunes L, Rello J, Colombo AL, Vena A, Munoz P, Tumbarello M, Sganga G, Martin-Loeches I, Viscoli C. Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality. Transplant Direct. 2017 Apr 18;3(5):e156. doi: 10.1097/TXD.0000000000000673. eCollection 2017 May. PMID: 28573191; PMCID: PMC5441987.
Copy Download .nbib Format: NLM
Author Correction: nr3c1 null mutant zebrafish are viable and reveal DNA-binding-independent activities of the glucocorticoid receptor.

Scientific reports

Facchinello N, Skobo T, Meneghetti G, Colletti E, Dinarello A, Tiso N, Costa R, Gioacchini G, Carnevali O, Argenton F, Colombo L, Valle LD.
PMID: 29520028
Sci Rep. 2018 Mar 08;8(1):4445. doi: 10.1038/s41598-018-21745-8.

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Cite
Facchinello N, Skobo T, Meneghetti G, et al. Author Correction: nr3c1 null mutant zebrafish are viable and reveal DNA-binding-independent activities of the glucocorticoid receptor. Sci Rep. 2018;8(1):4445doi: 10.1038/s41598-018-21745-8.
Facchinello, N., Skobo, T., Meneghetti, G., Colletti, E., Dinarello, A., Tiso, N., Costa, R., Gioacchini, G., Carnevali, O., Argenton, F., Colombo, L., & Valle, L. D. (2018). Author Correction: nr3c1 null mutant zebrafish are viable and reveal DNA-binding-independent activities of the glucocorticoid receptor. Scientific reports, 8(1), 4445. https://doi.org/10.1038/s41598-018-21745-8
Facchinello, N, et al. "Author Correction: nr3c1 null mutant zebrafish are viable and reveal DNA-binding-independent activities of the glucocorticoid receptor." Scientific reports vol. 8,1 (2018): 4445. doi: https://doi.org/10.1038/s41598-018-21745-8
Facchinello N, Skobo T, Meneghetti G, Colletti E, Dinarello A, Tiso N, Costa R, Gioacchini G, Carnevali O, Argenton F, Colombo L, Valle LD. Author Correction: nr3c1 null mutant zebrafish are viable and reveal DNA-binding-independent activities of the glucocorticoid receptor. Sci Rep. 2018 Mar 08;8(1):4445. doi: 10.1038/s41598-018-21745-8. PMID: 29520028; PMCID: PMC5843580.
Copy Download .nbib Format: NLM
Cellular and Molecular Targets of Benzo[a]pyrene and Metal Toxicity in Xenopus laevis Embryos and in Hep G2 Cells.

Alternatives to laboratory animals : ATLA

Camatini M, Bonfanti P, Colombo A, Urani C, Crippa S.
PMID: 25470671
Altern Lab Anim. 1999 May-Jun;27(3):325-37. doi: 10.1177/026119299902700321.

This paper describes the use of two in vitro systems (stage 35 Xenopus laevis embryos and the human hepatoblastoma cell line, Hep G2) to study effects of some environmental contaminants (benzo[a]pyrene, copper and zinc), which are representative of chemicals...

Cite
Camatini M, Bonfanti P, Colombo A, et al. Cellular and Molecular Targets of Benzo[a]pyrene and Metal Toxicity in Xenopus laevis Embryos and in Hep G2 Cells. Altern Lab Anim. 1999;27(3):325-37doi: 10.1177/026119299902700321.
Camatini, M., Bonfanti, P., Colombo, A., Urani, C., & Crippa, S. (1999). Cellular and Molecular Targets of Benzo[a]pyrene and Metal Toxicity in Xenopus laevis Embryos and in Hep G2 Cells. Alternatives to laboratory animals : ATLA, 27(3), 325-37. https://doi.org/10.1177/026119299902700321
Camatini, M, et al. "Cellular and Molecular Targets of Benzo[a]pyrene and Metal Toxicity in Xenopus laevis Embryos and in Hep G2 Cells." Alternatives to laboratory animals : ATLA vol. 27,3 (1999): 325-37. doi: https://doi.org/10.1177/026119299902700321
Camatini M, Bonfanti P, Colombo A, Urani C, Crippa S. Cellular and Molecular Targets of Benzo[a]pyrene and Metal Toxicity in Xenopus laevis Embryos and in Hep G2 Cells. Altern Lab Anim. 1999 May-Jun;27(3):325-37. doi: 10.1177/026119299902700321. PMID: 25470671.
Copy Download .nbib Format: NLM
Electrochemical nanoprobes for the chemical detection of neurotransmitters.

Analytical methods : advancing methods and applications

Shen M, Colombo ML.
PMID: 26327927
Anal Methods. 2015 Sep 07;7(17):7095-7105. doi: 10.1039/C5AY00512D.

Neurotransmitters, acting as chemical messengers, play an important role in neurotransmission, which governs many functional aspects of nervous system activity. Electrochemical probes have proven a very useful technique to study neurotransmission, especially to quantify and qualify neurotransmitters. With the...

Cite
Shen M, Colombo ML. Electrochemical nanoprobes for the chemical detection of neurotransmitters. Anal Methods. 2015;7(17):7095-7105doi: 10.1039/C5AY00512D.
Shen, M., & Colombo, M. L. (2015). Electrochemical nanoprobes for the chemical detection of neurotransmitters. Analytical methods : advancing methods and applications, 7(17), 7095-7105. https://doi.org/10.1039/C5AY00512D
Shen, Mei, and Colombo, Michelle L. "Electrochemical nanoprobes for the chemical detection of neurotransmitters." Analytical methods : advancing methods and applications vol. 7,17 (2015): 7095-7105. doi: https://doi.org/10.1039/C5AY00512D
Shen M, Colombo ML. Electrochemical nanoprobes for the chemical detection of neurotransmitters. Anal Methods. 2015 Sep 07;7(17):7095-7105. doi: 10.1039/C5AY00512D. PMID: 26327927; PMCID: PMC4551492.
Copy Download .nbib Format: NLM
Oxygen-activated growth and bandgap tunability of large single-crystal bilayer graphene.

Nature nanotechnology

Hao Y, Wang L, Liu Y, Chen H, Wang X, Tan C, Nie S, Suk JW, Jiang T, Liang T, Xiao J, Ye W, Dean CR, Yakobson BI, McCarty KF, Kim P, Hone J, Colombo L, Ruoff RS.
PMID: 26828845
Nat Nanotechnol. 2016 May;11(5):426-31. doi: 10.1038/nnano.2015.322. Epub 2016 Feb 01.

Bernal (AB)-stacked bilayer graphene (BLG) is a semiconductor whose bandgap can be tuned by a transverse electric field, making it a unique material for a number of electronic and photonic devices. A scalable approach to synthesize high-quality BLG is...

Cite
Hao Y, Wang L, Liu Y, et al. Oxygen-activated growth and bandgap tunability of large single-crystal bilayer graphene. Nat Nanotechnol. 2016;11(5):426-31doi: 10.1038/nnano.2015.322.
Hao, Y., Wang, L., Liu, Y., Chen, H., Wang, X., Tan, C., Nie, S., Suk, J. W., Jiang, T., Liang, T., Xiao, J., Ye, W., Dean, C. R., Yakobson, B. I., McCarty, K. F., Kim, P., Hone, J., Colombo, L., & Ruoff, R. S. (2016). Oxygen-activated growth and bandgap tunability of large single-crystal bilayer graphene. Nature nanotechnology, 11(5), 426-31. https://doi.org/10.1038/nnano.2015.322
Hao, Yufeng, et al. "Oxygen-activated growth and bandgap tunability of large single-crystal bilayer graphene." Nature nanotechnology vol. 11,5 (2016): 426-31. doi: https://doi.org/10.1038/nnano.2015.322
Hao Y, Wang L, Liu Y, Chen H, Wang X, Tan C, Nie S, Suk JW, Jiang T, Liang T, Xiao J, Ye W, Dean CR, Yakobson BI, McCarty KF, Kim P, Hone J, Colombo L, Ruoff RS. Oxygen-activated growth and bandgap tunability of large single-crystal bilayer graphene. Nat Nanotechnol. 2016 May;11(5):426-31. doi: 10.1038/nnano.2015.322. Epub 2016 Feb 01. PMID: 26828845.
Copy Download .nbib Format: NLM
Does Chronic Total Occlusion Percutaneous Coronary Intervention Improve Survival: A Never-Ending Debate.

JACC. Cardiovascular interventions

Azzalini L, Carlino M, Brilakis ES, Colombo A.
PMID: 27282606
JACC Cardiovasc Interv. 2016 Jun 13;9(11):1198-9. doi: 10.1016/j.jcin.2016.03.017.

No abstract available.

Cite
Azzalini L, Carlino M, Brilakis ES, et al. Does Chronic Total Occlusion Percutaneous Coronary Intervention Improve Survival: A Never-Ending Debate. JACC Cardiovasc Interv. 2016;9(11):1198-9doi: 10.1016/j.jcin.2016.03.017.
Azzalini, L., Carlino, M., Brilakis, E. S., & Colombo, A. (2016). Does Chronic Total Occlusion Percutaneous Coronary Intervention Improve Survival: A Never-Ending Debate. JACC. Cardiovascular interventions, 9(11), 1198-9. https://doi.org/10.1016/j.jcin.2016.03.017
Azzalini, Lorenzo, et al. "Does Chronic Total Occlusion Percutaneous Coronary Intervention Improve Survival: A Never-Ending Debate." JACC. Cardiovascular interventions vol. 9,11 (2016): 1198-9. doi: https://doi.org/10.1016/j.jcin.2016.03.017
Azzalini L, Carlino M, Brilakis ES, Colombo A. Does Chronic Total Occlusion Percutaneous Coronary Intervention Improve Survival: A Never-Ending Debate. JACC Cardiovasc Interv. 2016 Jun 13;9(11):1198-9. doi: 10.1016/j.jcin.2016.03.017. PMID: 27282606.
Copy Download .nbib Format: NLM
[Consequences of early failure in kidney transplant].

Minerva nefrologica

Cantaluppi A, Frontini A, Colombo A, Giorgianni V, Mecca G, Ponticelli C.
PMID: 7012688
Minerva Nefrol. 1980 Apr-Jun;27(2):275-7.

No abstract available.

Cite
Cantaluppi A, Frontini A, Colombo A, et al. Consequenze del fallimento porecoce del trapianto remale. [Consequences of early failure in kidney transplant]. Minerva Nefrol. 1980;27(2):275-7
Cantaluppi, A., Frontini, A., Colombo, A., Giorgianni, V., Mecca, G., & Ponticelli, C. (1980). Consequenze del fallimento porecoce del trapianto remale. [Consequences of early failure in kidney transplant]. Minerva nefrologica, 27(2), 275-7.
Cantaluppi, A, et al. "Consequenze del fallimento porecoce del trapianto remale." [Consequences of early failure in kidney transplant]. Minerva nefrologica vol. 27,2 (1980): 275-7.
Cantaluppi A, Frontini A, Colombo A, Giorgianni V, Mecca G, Ponticelli C. Consequenze del fallimento porecoce del trapianto remale. [Consequences of early failure in kidney transplant]. Minerva Nefrol. 1980 Apr-Jun;27(2):275-7. Italian. PMID: 7012688.
Copy Download .nbib Format: NLM
The polytetrafluoroethylene-covered stent: a device with multiple potential advantages.

International journal of cardiovascular interventions

Briguori C, Sarais C, Colombo A.
PMID: 12036469
Int J Cardiovasc Intervent. 2001 Sep;4(3):145-149. doi: 10.1080/146288401753514506.

The polytetrafluoroethylene (PTFE)-covered stent has emerged in the past year as a device with multiple potential advantages. Its structure (a sandwich composed of a layer of PTFE membrane between two stents) makes this the ideal tool for treating coronary...

Cite
Briguori C, Sarais C, Colombo A. The polytetrafluoroethylene-covered stent: a device with multiple potential advantages. Int J Cardiovasc Intervent. 2001;4(3):145-149doi: 10.1080/146288401753514506.
Briguori, C., Sarais, C., & Colombo, A. (2001). The polytetrafluoroethylene-covered stent: a device with multiple potential advantages. International journal of cardiovascular interventions, 4(3), 145-149. https://doi.org/10.1080/146288401753514506
Briguori, Carlo, et al. "The polytetrafluoroethylene-covered stent: a device with multiple potential advantages." International journal of cardiovascular interventions vol. 4,3 (2001): 145-149. doi: https://doi.org/10.1080/146288401753514506
Briguori C, Sarais C, Colombo A. The polytetrafluoroethylene-covered stent: a device with multiple potential advantages. Int J Cardiovasc Intervent. 2001 Sep;4(3):145-149. doi: 10.1080/146288401753514506. PMID: 12036469.
Copy Download .nbib Format: NLM
Multicenter evaluation of the phosphorylcholine-coated biodivYsio stent in short de novo coronary lesions: The SOPHOS study.

International journal of cardiovascular interventions

Boland JL, Corbeij HA, Van Der Giessen W, Seabra-Gomes R, Suryapranata H, Wijns W, Hanet C, Suttorp MJ, Buller C, Bonnier JJ, Colombo A, Van Birgelen C, Pieper M, Mangioni JA, Londero H, Carere RG, Hamm CW, Bonan R, Bartorelli A, Kyriakides ZS, Chauhan A, Rothman M, Grinfeld L, Oosterwijk C, Serruys PW, Cumberland DC.
PMID: 12431346
Int J Cardiovasc Intervent. 2000 Dec;3(4):215-225. doi: 10.1080/14628840050515966.

AIMS: The BiodivYsio trade mark stent (Biocompatibles Ltd, Farnham, UK) is coated with a phosphorylcholine (PC)-containing copolymer to confer biocompatibility. The SOPHOS (Study Of PHosphorylcholine coating On Stents) study was designed to assess the safety and efficacy of this...

Cite
Boland JL, Corbeij HA, Van Der Giessen W, et al. Multicenter evaluation of the phosphorylcholine-coated biodivYsio stent in short de novo coronary lesions: The SOPHOS study. Int J Cardiovasc Intervent. 2000;3(4):215-225doi: 10.1080/14628840050515966.
Boland, J. L., Corbeij, H. A., Van Der Giessen, W., Seabra-Gomes, R., Suryapranata, H., Wijns, W., Hanet, C., Suttorp, M. J., Buller, C., Bonnier, J. J., Colombo, A., Van Birgelen, C., Pieper, M., Mangioni, J. A., Londero, H., Carere, R. G., Hamm, C. W., Bonan, R., Bartorelli, A., Kyriakides, Z. S., Chauhan, A., Rothman, M., Grinfeld, L., Oosterwijk, C., Serruys, P. W., & Cumberland, D. C. (2000). Multicenter evaluation of the phosphorylcholine-coated biodivYsio stent in short de novo coronary lesions: The SOPHOS study. International journal of cardiovascular interventions, 3(4), 215-225. https://doi.org/10.1080/14628840050515966
Boland, J L, et al. "Multicenter evaluation of the phosphorylcholine-coated biodivYsio stent in short de novo coronary lesions: The SOPHOS study." International journal of cardiovascular interventions vol. 3,4 (2000): 215-225. doi: https://doi.org/10.1080/14628840050515966
Boland JL, Corbeij HA, Van Der Giessen W, Seabra-Gomes R, Suryapranata H, Wijns W, Hanet C, Suttorp MJ, Buller C, Bonnier JJ, Colombo A, Van Birgelen C, Pieper M, Mangioni JA, Londero H, Carere RG, Hamm CW, Bonan R, Bartorelli A, Kyriakides ZS, Chauhan A, Rothman M, Grinfeld L, Oosterwijk C, Serruys PW, Cumberland DC. Multicenter evaluation of the phosphorylcholine-coated biodivYsio stent in short de novo coronary lesions: The SOPHOS study. Int J Cardiovasc Intervent. 2000 Dec;3(4):215-225. doi: 10.1080/14628840050515966. PMID: 12431346.
Copy Download .nbib Format: NLM
Palmaz-Schatz stent embolization: long-term clinical and angiographic follow-up.

International journal of cardiovascular interventions

Briguori C, Kobayashi N, Gregorio JD, Colombo A.
PMID: 12623576
Int J Cardiovasc Intervent. 1999;2(4):247-248. doi: 10.1080/acc.2.4.247.248.

A long-term clinical and angiographic follow-up of a case of peripheral coronary stent embolization is reported. No clinical sequelae occurred in the immediate and long-term (five years) followup. The five-year follow-up angiographic images provided visual documentation of absence of...

Cite
Briguori C, Kobayashi N, Gregorio JD, et al. Palmaz-Schatz stent embolization: long-term clinical and angiographic follow-up. Int J Cardiovasc Intervent. 1999;2(4):247-248doi: 10.1080/acc.2.4.247.248.
Briguori, C., Kobayashi, N., Gregorio, J. D., & Colombo, A. (1999). Palmaz-Schatz stent embolization: long-term clinical and angiographic follow-up. International journal of cardiovascular interventions, 2(4), 247-248. https://doi.org/10.1080/acc.2.4.247.248
Briguori, Carlo, et al. "Palmaz-Schatz stent embolization: long-term clinical and angiographic follow-up." International journal of cardiovascular interventions vol. 2,4 (1999): 247-248. doi: https://doi.org/10.1080/acc.2.4.247.248
Briguori C, Kobayashi N, Gregorio JD, Colombo A. Palmaz-Schatz stent embolization: long-term clinical and angiographic follow-up. Int J Cardiovasc Intervent. 1999;2(4):247-248. doi: 10.1080/acc.2.4.247.248. PMID: 12623576.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 619 entries